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RESEARCH ARTICLE

Open Access

Identification of oxidized protein hydrolase as a
potential prodrug target in prostate cancer
Christopher A McGoldrick1, Yu-Lin Jiang2, Victor Paromov1, Marianne Brannon1, Koyamangalath Krishnan3
and William L Stone1*

Abstract
Background: Esterases are often overexpressed in cancer cells and can have chiral specificities different from that
of the corresponding normal tissues. For this reason, ester prodrugs could be a promising approach in
chemotherapy. In this study, we focused on the identification and characterization of differentially expressed
esterases between non-tumorigenic and tumorigenic prostate epithelial cells.
Methods: Cellular lysates from LNCaP, DU 145, and PC3 prostate cancer cell lines, tumorigenic RWPE-2 prostate epithelial
cells, and non-tumorigenic RWPE-1 prostate epithelial cells were separated by native polyacrylamide gel electrophoresis
(n-PAGE) and the esterase activity bands visualized using α-naphthyl acetate or α-naphthyl-N-acetylalaninate (ANAA) chiral
esters and Fast Blue RR salt. The esterases were identified using nanospray LC/MS-MS tandem mass spectrometry and
confirmed by Western blotting, native electroblotting, inhibition assays, and activity towards a known specific substrate.
The serine protease/esterase oxidized protein hydrolase (OPH) was overexpressed in COS-7 cells to verify our results.
Results: The major esterase observed with the ANAA substrates within the n-PAGE activity bands was identified as OPH.
OPH (EC 3.4.19.1) is a serine protease/esterase and a member of the prolyl oligopeptidase family. We found that LNCaP
lysates contained approximately 40% more OPH compared to RWPE-1 lysates. RWPE-2, DU145 and PC3 cell lysates had
similar levels of OPH activity. OPH within all of the cell lysates tested had a chiral preference for the S-isomer of ANAA.
LNCaP cells were stained more intensely with ANAA substrates than RWPE-1 cells and COS-7 cells overexpressing OPH
were found to have a higher activity towards the ANAA and AcApNA than parent COS-7 cells.
Conclusions: These data suggest that prodrug derivatives of ANAA and AcApNA could have potential as
chemotherapeutic agents for the treatment of prostate cancer tumors that overexpress OPH.

Background
Prostate cancer is the second most frequently diagnosed
cancer in men and the second-leading cause of cancer
related death in American men [1]. There is an estimated
238,590 new cases of prostate cancer predicted in the US
this year and an estimated 29,720 deaths due to prostate
cancer [1]. Despite advances in radiation and chemotherapy, prostate cancer is a leading cause of cancer death.
Radiation and chemotherapy treatment remain central to
prostate cancer treatment. These treatments can, however,
produce a number of side effects such as neutropenia
[2,3], urinary and bowel symptoms [4], hair loss [5], and
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fatigue [6]. There is, therefore, a critical need to develop
tumor specific therapies for prostate cancer.
Selective activation of anti-cancer drugs within cancer
cells is a promising strategy to minimize the toxic effects
of anticancer drugs on normal tissues [7-10]. As indicated in Figure 1, the esterase prodrug strategy utilizes
pharmacological compounds that are blocked by esterification but are activated when cancer cell esterases cleave
the ester bond and release the active drug [11]. A degree
of specificity can be achieved if the cancer cell esterase
is overexpressed compared to normal tissue. In order to
optimize potential chemotherapeutic prodrug esters it is
important to characterize and identify any differentially
expressed esterases.
Yamazaki et al. [12-14] examined the esterase activity
profiles of various human and animal cancer tumors using
n-PAGE and esterase activity staining. These researchers
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Figure 1 Esterase activity profiling and the esterase prodrug strategy proposed by Yamazaki et al. utilize the same mechanism for
activation. A) The active compound is blocked with an ester linker to an inactive compound such as N-acetyl-alanine. B) The compound is
activated within the target cell by target esterase(s). C) The prodrug is unblocked and induces cell death in the target cell. Esterase activity staining with
ANAA substrates releases naphthyl alcohol upon hydrolysis that reacts with Fast Blue RR, a diazonium salt, to form an insoluble product.

found that lysates from cancer tumors often had a different
level of activity and a different stereoselectivity towards several chiral esters than the corresponding normal tissues.
Moreover, Yamazaki et al. suggested these differences
in esterase activities could be exploited to develop prodrugs
that selectively target cancer cells [13,14]. The esterases
observed by Yamazaki et al. [12-14] were, however, never
identified. The primary focus of the work presented here
was to identify the specific esterases differentially expressed
in tumorigenic human prostate cancer cells and in nontumorigenic prostate epithelial cells. We compared the
esterase activity profiles of RWPE-2, LNCaP, DU 145, and
PC-3 tumorigenic prostate cell lines to RWPE-1 nontumorigenic prostate epithelial cells using the α-naphthyl
acetate substrate and the chiral naphthyl ester substrates
α-naphthyl N-acetyl-S-alaninate (S-ANAA) and α-naphthyl
N-acetyl-R-alaninate (R-ANAA). These substrates were
previously used by Yamazaki et al. [13]. Figure 2 shows
the structures of the various substrates. In addition, we
have advanced the Yamazaki method of detecting esterases
by using a native electroblot method that markedly increases the sensitivity for detecting esterase activity bands
compared to that observed in n-PAGE gels.
We identified oxidized protein hydrolase (OPH), also
called N-acylaminoacyl-peptide hydrolase (APEH), as a key
esterase that is overexpressed in the tumorigenic LNCaP
cell line. OPH is a serine esterase/protease that has a well
characterized esterase activity towards α-naphthyl butyrate

[15] and an exopeptidase activity for removing the
N-terminally acetylated amino acid residues from peptides/
proteins [15-17]. Immunohistochemistry of primary prostate tumor sections indicate that OPH is highly expressed
in some prostate tumors (http://www.proteinatlas.org/),
suggesting that OPH could have potential as a drug target
in prostate cancer. The overexpression of OPH in some
prostate cancers suggests that chemotherapeutic prodrugs
esters modeled after known ester substrates of OPH
(i.e., α-naphthyl N-acetyl-alaninate) have potential in
treating some prostate cancers.

Methods
Materials

Porcine liver esterase (PLE), digitonin, α-naphthyl acetate,
fast blue RR salt, goat anti-rabbit HRP conjugate polyclonal
antibody, and diisopropyl fluorophosphate (DFP) were
purchased from Sigma Chemical Company (St. Louis, MO).
Novex Tris-glycine native sample buffer, NuPAGE LDS
sample buffer, Novex Tris-glycine gels, NativeMark
unstained protein standards, Protein A agarose beads,
penicillin/streptomycin solution, and geneticin (G418)
were purchased from Invitrogen (Grand Island, NY).
Precision plus protein standards were purchased from
Bio-Rad (Hercules,CA); the BCA kit and the In-gel tryptic
digestion kit were purchased from Pierce (Rockford, IL);
ZipTipU-C18 tips were purchased from Millipore (Billerica,
MA); 3,3′,5,5′-tetramethylbenzidine (TMB) was purchased
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Figure 2 Structures of compounds used to evaluate esterase activity profiles. A) α-naphthyl acetate is a non-specific esterase substrate and
is used to visualize general esterase activity. B) S-ANAA and C) R-ANAA are chiral esters previously used by Yamazaki et al. to demonstrate
stereoselective preferences between cancer and normal cells. D) N-acetyl-L-alanyl-p-nitroanilide releases p-nitroanaline upon hydrolysis and is
routinely used to monitor OPH activity.

from Promega (Madison, WI); rabbit polyclonal anti-AARE
antibody was purchased from Abcam (Cambridge, MA);
superose 12 column (10/300 GL) was purchased from GE
Healthcare (Pittsburgh, PA); (TransIT-LT1 transfection
reagent was purchased from Mirus Bio (Madison, WI).
pCDNA3.1(+) vector encoding OPH-Flag was a kind gift
from Dr. M. Hayakawa (Tokyo University of Pharmacy and
Life Sciences, Tokyo, Japan).
Substrates

R- and S- isomers of ANAA (Figure 2) were synthesized
and purified as previously described [13] and stored
at -20°C. Stock solutions of 100 mM α-naphthyl acetate
were prepared in DMSO and stored at -20°C. The synthesis
of N-acetyl-alanyl-p-nitroanilide (AcApNA) was guided by
a previously published procedure [18]. AcApNA was synthesized by adding 20 ml of dichloromethane to a solution
of anhydrous dimethylformamide (0.51 ml) and 0.865 g of
N-acetyl-L-alanine. The mixture was cooled to -20°C with
an acetone-dry ice bath. Thionyl chloride (0.485 ml) was
added dropwise to the cooled mixture. After 20 min, a cold
solution (-20°C) of 0.828 g 4-nitroanaline and 1.82 ml of
triethylamine in 10 ml of dichloromethane was added dropwise to the N-acetyl-L-alanine solution. The resulting mixture was maintained at 0°C for 2 h. After concentration, the
mixture was extracted with ethyl acetate (2 × 30 ml). The
organic layer was washed with 4 N HCl (2 × 40 ml) and
NH4Cl aqueous solution (40 ml), and dried over MgSO4.
After filtration and concentration of the organic layer, the
residue was purified using column chromatography with

hexane, then 30-50% acetone in hexane, affording 0.248 g
of the final product (16%). M.P. was found to be 194-196°C.
The M.P. has been previously reported as 192-197°C [19]).
Cell culture and lysates

RWPE-1 (CRL-11609), RWPE-2 (CRL-11610), LNCaP
(CRL-1704), DU-145 (HTB-81), PC-3 (CRL-1435) and
COS-7 (CRL-1651) cell lines were purchased from American
Type Culture Collection (Manassas, VA), cultured according
to ATCC’s instructions and supplemented with 100 U/ml
penicillin and 100 mg/ml streptomycin. Cells were detached from the 75 cm3 cell culture flasks after reaching
80% confluence by washing the cells with PBS followed
by the addition of 0.25% trypsin. The detached cells
were centrifuged at 500 × g for 5 mins and washed with
PBS to remove trypsin. Cells were centrifuged a second
time and pellets stored at -80°C. Cell pellets of each cell
line were lysed using 2% (wt/vol) digitonin in PBS on ice
with vortexing every two minutes. After 10 min of incubation on ice, the lysates were centrifuged at 18,000 × g
for 5 min at 4°C and the supernatant collected. Protein
concentrations were determined with the BCA kit using
the manufacturer’s instructions.
n-PAGE esterase activity profiles

Cell lysates containing 120 μg of protein were mixed with
an equal volume of 2X Novex Tris-glycine native sample
buffer and applied to a Novex 10-20% or 6% Tris-glycine
gel. NativeMark unstained protein standards were used as
migration markers. Gels were electrophoresed under native
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conditions at 4°C using 20 mA/gel for 270 min for the
10-20% gel or 180 min for the 6% gels. For inhibition assays, the gel lanes were separated and immersed in either
0.1 M sodium phosphate buffer, pH 6.5 or sodium phosphate buffer containing 50 μM DFP for 10 min. The gels
were then stained for esterase activity by immersing them
in 30 ml of 0.1 M sodium phosphate buffer, pH 6.5 containing 10 mg Fast Blue RR Salt and 800 μM α-naphthyl acetate
or 800 μM ANAA isomer. Bands were developed at room
temperature for 30 min followed by 3 washes with distilled
water. The migration markers were stained with Coomassie
blue and destained overnight in 10% acetic acid. Gels were
scanned with an Epson Perfection V750 PRO scanner.
Semi-purified OPH from rat liver

OPH was semi-purified from 100 g of rat liver using the
method described by Tsunasawa [20] with the following
modifications. After elution from the hydroxyapatite
column, the OPH fractions were combined and subjected
to gel filtration on a Superose12 column (10/300 GL) using
a Biologic Duo Flow protein purification system (Bio-Rad,
Hercules,CA). Fractions were eluted with 50 mM sodium
phosphate buffer, pH 7 containing 1 mM EDTA and 0.2 M
NaCl at a rate of 0.5 ml/min in 0.5 ml fractions. Fractions
that contained OPH activity were combined and stored
at -20°C. The pooled semi-purified OPH was analyzed
by mass spectroscopy to verify that no other esterases
or proteases were present.
Overexpression of OPH in COS-7 cells

COS-7 cells were transfected using TransIT-LT1 transfection reagent and the vector pCDNA3.1(+) encoding OPH
with a Flag tag using the transfection reagent’s manufacturer’s instructions. COS-7 cells overexpressing OPH were
selected using 1 mg/ml G418 over a three week period. Cells
surviving selection were termed COS-7-OPH for further
experiments and were maintained with 1 mg/ml G418.
LC/MS-MS mass spectroscopy

Protein bands were individually excised from the n-PAGE
gel and cut into small pieces using a scalpel. The gel pieces
were destained, disulfide bonds reduced, unmodified
thiol groups alkylated, and the proteins digested with
trypsin overnight using the In-Gel Tryptic Digestion Kit
(Pierce, Rockford, IL) according to the manufacturer’s
instructions. After digestion, the liquid containing the
peptides from each band was transferred to a 1.5 ml tube.
The peptides were further extracted from each gel piece
by covering gel piece with extraction buffer consisting of
formic acid/acetonitrile/water (5:50:45, v/v/v) for 10 min
then collecting the liquid and adding it to the appropriate 1.5 ml tube. The peptides in the vial inserts were
completely dried using a DNA Speed Vac Concentrator
(Thermo Fisher Scientific, Asheville, N.C.). Peptides were
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rehydrated with 0.1% formic acid and further purified
using ZipTipU-C18 tips according to manufacturer’s instructions. Peptides eluted from zip tips were transferred
to vial inserts. The peptides in the vial inserts were completely dried using the Speed Vac Concentrator and then
rehydrated in a volume of 4 μl of formic acid/acetonitrile/
water (0.1:20:79.9, v/v/v). A volume of 2 μl of each sample
was trapped by a picofrit column packed with C18 (New
Objective, Inc., Woburn, MA) and equilibrated in 0.1%
formic acid in water/acetonitrile (98:2, v/v). Peptides were
then eluted with a gradient of 2 to 40% of solvent B containing 0.1% formic acid in acetonitrile over 60 min at a
flow rate of 200 nL/min. Eluted peptides were analyzed by
electrospray ionization using a LTQ-XL ion trap mass
spectrometer (Thermo Fisher). Mass spectrometry (MS)
data were acquired using data-dependent acquisition with
a series of one full scan followed by a zoom scan and then
a MS/MS scan of the ions. The dynamic exclusion duration
was 30 ms. Proteins were identified from each MS raw data
file using the SEQUEST search algorithm (Thermo Fisher
Scientific) and the SwissProt/UNIPROT database through
the Bioworks browser, version 3.3.
SDS-electrophoresis/Western blotting

Cell lysates containing 90 μg of protein were mixed with
NuPAGE LDS Sample Buffer, heated to 90°C, and applied
to a Novex 10-20% Tris-Glycine gel. Precision Plus Protein
Standards were used for molecular weight markers. Gels
were electrophoresed for 90 min at 125 V in 1X Novex
Tris-Glycine SDS running buffer. Gels were then electrophoretically transferred to a nitrocellulose membrane
for 90 min at 25 V. The membrane was probed with
1:1000 rabbit polyclonal anti-AARE (OPH) antibody
(ab84694, Abcam) or anti-GAPDH (ab9485, Abcam)
overnight at 4°C, 1:2000 anti-rabbit IgG conjugated to
HRP (A0545-1ML, Sigma) was used as the secondary
antibody and incubated for 1 hour. Membranes were
washed with PBS containing 0.05% Tween 20. Peroxidase was detected using 3,3′,5,5′-tetramethylbenzidine
according to manufacturer’s instructions.
Native electroblot activity staining and western blotting

Native electroblot activity staining was carried out by electrophoretically transferring proteins from n-PAGE gels to
a nitrocellulose membrane at 4°C, followed by the esterase
activity staining procedure (see above). Western blots of
the n-PAGE gel were carried out by probing a native electroblot as described in the Western blotting methods.
OPH-cleared lysate

An aliquot of 0.5 ml Protein A agarose beads was coupled
with 5 μg of anti-OPH antibody on ice for 30 min. LNCaP
cell lysates containing 120 μg of protein was combined with
either Protein A agarose beads or anti-OPH conjugated
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Protein A agarose beads and incubated on ice for 1 hour
with gentle mixing every 15 min. The samples were centrifuged for 5 min at 1000 × g and the supernatants were
then separated using 6% n-PAGE followed by the esterase
activity staining procedure.
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because the cell lines are publicly available and all of the
information known about the cell lines is also publicly
available. No experimental animals were used in the studies
reported here.

Results
OPH activity assay

Aliquots of 20 μL of cell lysates containing either 4.5 μg/μl
of protein, or 0.5 unit PLE, or 12.5 ng/μl semi-purified rat
liver OPH, or PBS were added in triplicate to a 96 well
microplate. One unit of PLE is defined as the amount
of PLE that will hydrolyze 1.0 μmole of ethyl butyrate
to butyric acid and ethanol per min at pH 8.0 at 25°C.
An assay cocktail of 220 μL 0.1 M sodium phosphate
buffer, pH 6.5 and 10 μl of 100 mM AcApNA was
added to each well giving a final AcApNA concentration
of 4 mM. The release of p-nitroaniline was monitored
with a microplate reader at a wavelength of 405 nm
for 10 min at room temperature. The concentration of
p-nitroaniline was calculated using a molecular extinction
coefficient of 7530 M-1 cm-1.
Cell culture esterase staining

LNCaP, RWPE-1, COS-7, and COS-7-OPH were seeded
in triplicate in 24 well cell culture plates at 1x105 cells/well.
The plate was incubated at 37°C in a CO2 incubator overnight. Staining solutions of 0.1 M sodium phosphate buffer,
pH 6.5 containing 10 mg Fast Blue RR Salt and 800 μM
α-naphthyl acetate or 800 μM α-naphthyl N-acetylalaninate
isomer were prepared immediately prior to cell staining.
The cell media was removed from each well and 500 μl of
staining solution was added to each well. The cells were
incubated at 37°C in 5% CO2 for 20 minutes. The staining
solution was removed and replaced with 500 μl of PBS.
The cells were observed at 100x magnification and digitally photographed using a MOTIC inverted phase contrast microscope equipped with a Nikon Coolpix E4300
4-megapixel camera (Martin Microscope, Easley, SC).
The percent area threshold of staining was measured using
ImageJ, v1.44o (NIH, Bethesda, MD).
Statistics

Data were analyzed by analysis of variance (ANOVA)
followed with the Scheffe test for significance with P < 0.05
using SPSS 19.0 for Windows (Chicago, Illinois). Results
were expressed as the mean ± SD of at least three experiments. In all figures, letters that are not the same are
significantly different with P < 0.05.
Ethics

The research conducted in this study adhered to US NIH
ethical guidelines. All the human cell lines studied were
purchased from the American Type Culture Collection and
such studies are not considered human subjects research

Differential esterase activity between non-tumorigenic
RWPE-1 and tumorigenic LNCaP cells

Our first objective was to determine if non-tumorigenic
prostate cells have a different n-PAGE esterase activity
profile compared to tumorigenic prostate cells and to
characterize any chiral ester substrate preferences.
Proteins from non-tumorigenic RWPE-1 and tumorigenic
LNCaP human prostate cell lysates were separated by
n-PAGE on a 10-20% gradient gel and stained for esterase activity (Figure 3A) using either α-naphthyl acetate,
R-ANAA, or S-ANAA substrates (Figure 2A-C) and Fast
Blue RR salt. General esterase activity, as visualized by
α-naphthyl acetate activity staining [21,22], was markedly
higher in the tumorigenic LNCaP lysate compared to the
non-tumorigenic RWPE-1 lysate. Parallel gels stained with
either R-ANAA or S-ANAA substrates revealed fewer
esterase bands than with α-naphthyl acetate. The chiral
substrates revealed two prominent bands that migrated
at native protein molecular weight markers locations
corresponding to “432 kDa” and “359 kDa”. Protein migration in n-PAGE electrophoresis is influenced by size,
conformation and charge and, therefore, the “native kDa
markers” in Figure 3A were used only to provide a reproducible measure of electrophoretic migration patterns rather
than a meaningful measure of true molecular weight. As
shown in Figure 3A, both the “432 kDa” and the “359 kDa”
bands were markedly more stained in the LNCaP cell lysates compared to the RWPE-1 cell lysates and both bands
showed higher staining with S-ANAA compared to the
R-ANAA chiral substrate. Densitometry analysis of the
432 kDa and 359 kDa esterase bands (Figure 3B-C) showed
approximately a 30% increase in activity with S-ANAA
compared to R-ANAA and approximately 40% more activity with LNCaP lysates compared to RWPE-1 lysates.
Prostate esterases identified as OPH have a preference
for S-ANAA

Initial attempts to identify the esterases within the
“432 kDa” and “359 kDa” bands by LC/MS-MS were
hindered by the large number of non-esterase proteins.
To further characterize esterase activity in human prostate
cells, we next examined cell lysates of several human
prostate cell lines for esterase activity using 6% n-PAGE
followed by activity staining with α-naphthyl acetate, or
chiral ester substrates R-ANAA, or S-ANAA (Figure 4A).
By performing 6% n-PAGE electrophoresis, the higher MW
proteins were better separated and esterase bands generally more defined. The n-PAGE esterase activity profiles
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Figure 3 Non-tumorigenic RWPE-1 and tumorigenic LNCaP
prostate cell lysates display differential esterase activity and
substrate specificity. A) Non-tumorigenic RWPE-1 and tumorigenic
LNCaP cell lysates containing 120 μg of protein were separated on a
native 10-20% polyacrylamide gel. The gels were stained with 800 μM
α-naphthyl acetate, R-ANAA, or S-ANAA substrate and Fast Blue RR salt.
Native molecular weight markers (left side) were used to estimate the
relative migration of some esterase bands (right side). B) The 359 kDa
n-PAGE LNCaP and RWPE-1 esterase bands stained with R-ANAA or
S-ANAA were measured by densitometry. C) The 432 kDa n-PAGE LNCaP
and RWPE-1 esterase bands were also measured by densitometry. Letters
that are not the same are significantly different at P < 0.05.

obtained with α-naphthyl acetate showed diffuse bands
in the 720 to 1048 kDa native protein marker range for
LNCaP, DU145 and PC3 cell lysates that were faintly
present in the RWPE-1 or RWPE-2 cell lysates. The
staining intensity with α-naphthyl acetate in the 720 to
1048 kDa region was greater for the LNCaP, DU145 and
PC3 cell lysates compared to the RWPE-1 or RWPE-2
cell lysates.
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Parallel gels stained with S-ANAA or R-ANAA show
two prominent and sharp esterase bands at 216 kDa and
198 kDa native protein marker points. Densitometry analysis of the 216 kDa band showed significantly higher esterase activity in the LNCaP cell lysate stained with R-ANAA
and S-ANAA compared to all other cell lysates (Figure 4B).
Moreover, the 216 kDa band for LNCaP cells showed
higher activity with the S-ANAA substrate compared to
the R-ANAA substrate. The degree of chiral substrate
selectivity was more apparent in the esterase activity of the
198 kDa band (Figure 4C). Densitometry of the 198 kDa
band showed a significant preference for S-ANAA substrate in all of the cell lines except DU 145. The LNCaP
lysates contained 40-50% higher esterase activity in both
bands with S-ANAA substrate than with the R-isomer
and a 40-60% higher activity compared to RWPE-1 lysate.
RWPE-2 and PC3 lysates had similar staining profiles to
RWPE-1, while DU 145 showed less activity compared
to RWPE-1.
The n-PAGE esterase profiles obtained with S- or RAANA showed fewer and more distinct bands than with
the α-naphthyl acetate. We, therefore, focused on determining the identity of the protein(s) in the more active
198 kDa band. This band was excised, trypsinized, and
the resulting peptides were subjected to mass spectrometry analysis to identify the esterase(s) responsible for
the activity. As shown in Table 1, we identified oxidized
protein hydrolase (OPH), also called N-acylaminoacylpeptide hydrolase, or acylamino-acid-releasing enzyme
(EC 3.4.19.1) in the 198 kDa band. OPH is a serine esterase/
protease with a well characterized exopeptidase activity
for removing N-terminally acetylated residues from peptides
[15-17]. These LC-MS/MS results as well as the hydrolysis
of the ANAA substrates by the 198 kDa band are consistent
with the known activity of OPH to remove N-terminally
acetylated alanine residues.
LNCaP lysates showed significantly higher levels of
esterase activity with α-naphthyl acetate and ANAA
substrates compared to non-tumorigenic RWPE-1 and
tumorigenic RWPE-2, DU145 and PC3 cell lysates. It
appears clear that not all tumorigenic prostate cells contain
high levels of OPH activity; however, the human protein
atlas (http://www.proteinatlas.org/) indicates that some
human tumors overexpress OPH compared to normal
prostate tissue. Since the overexpression of OPH in tumors
compared to normal prostate tissue is the most ideal situation for OPH targeted prodrugs, we have limited the remainder of this study to the non-tumorigenic RWPE-1 and
tumorigenic LNCaP cell lines.
Esterase activity profiles with n-PAGE electroblotting

In order to further validate the nanospray-LC-MS/MS
results we next tested the possibility that: (1) esterase
activity could be maintained after n-PAGE electroblotting;
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Figure 4 Prostate cell lysate esterases form distinct bands when separated by 6% n-PAGE. A) RWPE-1, RWPE-2, LNCaP, DU 145, and PC3
cell lysates containing 120 μg of protein were separated by 6% n-PAGE followed by staining with either 800 μM α-naphthyl acetate, S-ANAA, or
R-ANAA. Native molecular weight markers (left side) were used to calculate the relative migration of some esterase bands (right side). The B)
216 kDa and C) 198 kDa esterase bands visualized with S-ANAA were measured by densitometry. Letters that are not the same are significantly
different at P < 0.05.

(2) immunostaining could be used to confirm the presence of OPH protein in the n-PAGE esterase activity
bands; (3) nanospray-LC-MS/MS could be performed on
the electroblotted esterase bands. RWPE-1 and LNCaP lysates were separated on 6% n-PAGE gels and the proteins
transferred to a nitrocellulose membrane by electroblotting and the esterase bands visualized by activity staining
of the membrane with S-ANAA substrate. As shown in
Figure 5A, this methodology resulted in the appearance of
two additional sharp bands in the 220-240 kDa native

protein marker region of the blot. A parallel blot was
probed with anti-OPH antibody to confirm the proteomic
identification of OPH within the activity bands. The esterase activity was quantified using densitometry analysis
(Figure 5B) and the LNCaP activity bands showed about a
50% higher esterase activity compared to the respective
RWPE-1 activity bands. Densitometry of the anti-OPH
immunoblot (Figure 5C) revealed relative intensity patterns that paralleled that seen for the activity bands. The
four OPH activity bands were excised separately and each
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Table 1 LC/MS-MS analysis of 198 kDa n-PAGE bands
Protein Identical

P

MW(Da)

N-acylaminoacyl-peptide hydrolase (OPH)

3.116E-08

81172.77

P

MW(Da)

R.LLLYPK.S

OPH Peptides Indentified

4.144E-01

136.96

K.TPLLLMLGQEDR.R

3.128E-07

440.43

R.SALYYVDLIGGK.C

1.171E-07

1180.98

K.STHALSE VE VE SDSFMNAVLVVLR.T

1.159E-01

213.91

KVGFLP SAGK.E

5.348E-01

280.19

K.ALDVSASDDEIAR.L

2.568E-07

1461.57

K.VTSVVVDVVPR.Q

1.285E-04

966.14

K.SFNLSALEK.H

2.434E-03

512.27

K.QFLEVWEK.N

2.718E-04

201.26

R.GSTGFGQDSILSLPGNVGHQDVK.D

4.639E-02

266.86

K.MGFAVLLVNYR.G

1.412E-01

1143.36

R.SALYYVDLIGGK.C

5.262E-01

567.34

K.GDQFVFYEDWGENMVSK.S

7.935E-02

195.47

R.QDLFAVDTQVGTVTSLTAGGSGGSWK.L

3.116E-08

323.53

K.EQSVLWVSLEEAEPIPDIHWGIR.V

8.643E-02

382.15

A representative list of OPH peptide identified within the 198 kDa esterase
band by mass spectrometry. Peptide coverage was 24.6% of the full OPH
protein sequence. P indicate the probability that the protein or peptide is a
random match to the spectral data.

band analyzed by LC/MS-MS. As detailed in Table 2,
OPH was identified within the most active activity bands
(bands 2-4) but could not be consistently identified within
the least active band (band 1). We also noted that the esterase activity profiles with n-PAGE electroblotting had a
lower level of background staining than similarly stained
native gels.
OPH accounts for the all the esterase staining observed
with the S-ANAA substrate

We next investigated whether the apparent esterase activity with the S-ANAA substrate observed in the 198
and 216 kDa bands was due completely to OPH. NativePAGE gels run with LNCaP or RWPE-1 lysates were preincubated with 50 μM diisopropyl fluorophosphate (DFP),
a known irreversible inhibitor of serine esterases/proteases
and of OPH [23], before activity staining with S-ANAA
substrate (Figure 6A). The 198 kDa and 216 kDa esterase
bands showed no visible activity after pre-incubation with
DFP, indicating that the esterase activity observed was
completely due to a serine hydrolase activity. We further
confirmed this finding by pre-clearing the cell lysates with
anti-OPH antibody prior to n-PAGE esterase activity profiling (Figure 6B). Activity staining with S-ANAA revealed
that cell lysates pre-cleared with anti-OPH antibody had
no detectable esterase activity further confirming that the
esterase activity observed with S-ANAA was due specifically and completely to OPH.

OPH present in prostate cell lysates appears as a single
MW weight species in SDS-PAGE Westerns

Since we observed multiple OPH bands in prostate cell
lysates with n-PAGE, we next wanted to determine if
SDS-PAGE gels similarly had multiple bands or a single
OPH polypeptide with the known MW (81 kDa) of the
OPH monomer. Western blots of non-tumorigenic RWPE1 and tumorigenic LNCaP, DU 145, and PC3 cell lysates
were found to be a single 81 kDa band (Figure 7A). Densitometry analysis showed significant differences in OPH expression levels among the four cell lines (Figure 7B). LNCaP
cell lysates contained approximately 40% more OPH than
RWPE-1, while DU 145 and PC3 lysates contained less
OPH (50% and 25% respectively) than RWPE-1.
Mammalian OPH has been primarily reported as a
homotetramer [16,24,25] with each OPH subunit being
active within the tetramer. It has been shown that citraconylation of the amino groups of purified OPH tetramer
reversibly dissociates the quaternary structure of OPH.
When acylated with citraconic anhydride, OPH separated
by n-PAGE forms multiple OPH bands [26]. Interestingly,
our prostate cell lysates produced four uniformly distributed activity bands when separated by n-PAGE.
Some explanations for the multiple OPH activity bands are
OPH multi-mers, isoforms, degradation products, protein
interactions, and post-translational modifications. OPH
isoforms and degradation products appear to be unlikely
causes for the multiple bands. Isoforms and degredation
products typically result in multiple bands when separated
by SDS-PAGE; however, western blots of the prostate
lysates reveal a single 80kD OPH band. The interaction
of native OPH with other proteins is plausible.
There is evidence that under conditions of oxidative
stress OPH translocates to the cell membrane of erythrocytes and degrades oxidized proteins [27]. Similarly,
OPH was found to translocate to the aggresome when
the proteasome was inhibited in COS-7 cells [28]. High
levels of oxidative stress are known to oxidize proteins
resulting in protein aggregations that can inhibit the
proteasome [29]. LNCaP, DU 145, and PC3 cell lines
are reported to have significantly higher free radical
production compared to RWPE-1 [30], which might
induce OPH to interact with aggresomal or membrane
proteins. Our mass spectrometry analysis of the OPH
bands revealed several proteins known to be associated
with aggresomes and were consistent with previously
published data [31]. We are actively pursuing an explanation for the multiple OPH bands.
The higher expression of OPH protein in LNCaP cell
lysates is reflected by a higher activity towards
N-acetyl-alanyl-p-nitroanilide

N-acetyl-alanyl-p-nitroanilide (AcApNA) (Figure 1D)
is a specific OPH substrate and is routinely used to
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Figure 5 Native electroblot activity staining and anti-OPH reveal OPH bands. LNCaP and RWPE-1 cell lysates each containing 120 μg
of protein were subjected to 6% n-PAGE followed by electroblot transfer to a nitrocellulose membrane. A) The blot was stained with
800 μM S-ANAA and Fast Blue RR salt. A parallel unstained blot was probed with anti-OPH as stated in the Materials and methods section.
B) The esterase activity and C) anti-OPH bands were measured by densitometry and expressed in arbitrary units (A.U.). Letters that are not
the same are significantly different at P < 0.05.

measure OPH activity and follow OPH purification
from tissue homogenates [16,24,25,28]. The product
p-nitroaniline (p-NA) is released upon hydrolysis of
AcApNA and its absorbance measured at 405 nm. We
found that non-tumorigenic and tumorigenic cell lysates
incubated with AcApNA released p-NA at differential
rates (Figure 7B). After 10 minutes of incubation with
AcApNA, LNCaP lysates released approximately 40%
more p-NA than RWPE-1 lysates. PC3 lysates released
approximately 15% more p-NA compared to RWPE-1,
while the rates for AcApNA hydrolysis were similar for
DU 145 and RWPE-1. The activity profile of the prostate
cell lysates incubated with the known OPH substrate
AcApNA parallel the expression of OPH observed by
SDS-PAGE Western blots (Figure 7A) as well as the
esterase activity profiles observed for n-PAGE stained
with S-ANAA. As expected, porcine liver esterase (PLE)
had no activity towards the AcApNA substrate.
The esterase substrates enter prostate cells and have
measurable in situ esterase activities

As indicated in Figure 8, we next compared the esterase
activities within LNCaP and RWPE-1 cultured prostate

epithelial cells by incubating intact cells with α-naphthyl
acetate or the chiral ANAA substrates. We found that
LNCaP cells had higher in situ esterase activity with all
three substrates compared to RWPE-1 (Figure 8A). Analyses
of the areas stained (Figure 8B) showed that α-naphthyl
acetate stained LNCaP cells approximately three-fold more
than RWPE-1 cells. RWPE-1 cells showed no significant
difference in staining between the chiral ANAA substrates;
however, the LNCaP cells had a five-fold higher esterase
activity level with S-ANAA compared to R-ANAA. LNCaP
cells also had five-fold higher activity with S-ANAA than
RWPE-1 cells. These data clearly demonstrate that the ester
substrates are permeable to the plasma membrane, which
is typical of neutral esters.
Human OHP overexpressed in COS-7 has characteristics similar
to that of OPH in the human prostate epithelial cell lines

As a positive control, we next repeated the in situ experiment with COS-7 cells and COS-7-OPH cells which
overexpress OPH (Figure 9A). As expected, based on our
n-PAGE experiments (Figure 4A), there was no increase in
COS-7-OPH with in situ staining when α-naphthyl acetate
was used since it was not found to be a substrate for OPH.
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Table 2 Electroblot esterase activity bands contain OPH
B and 2
Protein Identified
N-acylaminoa cly-peptide hydrolase
Peptides Identified

P

MW(D a)

3.710E-05

81172.77

P

MW(D a)

R.QVLLSEPEEAAALYR.G

1.230E-02

556.27

K.ALDVSASDDEIAR.L

5.072E-01

103.52

K.SFNLSALEK.H

8.916E-01

159.19

K.AESFFQTK.A

9.150E-01

159.21

R.VVFDSAQR.S

8.716E-01

113.36

R.QVLLSEPEEAAALYR.G

4.985E-05

439.67

P

MW(D a)

B and 3
Protein Identified
N-acylaminoacyl-peptide hydrolase

1.857E-07

81172.77

P

MW(D a)

R.QVLLSEPEEAAALYR.G

1.857E-07

1185.89

R.GSTGFGQDSILSLPGNVGHQDVK.D

3.389E-04

541.33

K.TPLLLML GQEDR.R

2.792E-05

1402.32

R.NVPVR.D

9.825E-01

91.84

P

MW(D a)

Peptides Identified

B and 4
Protein Identified
N-acylaminoacyl-peptide hydrolase
Peptides Identified

4.579E-05

81172.77

P

MW(D a)

K.SPIR.Y

9.457E-01

36.07

K.SFNLSALEK.H

9.684E-01

338.72

R.QVLLSEPEEAAALYR.G

4579E-05

1022.76

LC/MS-MS of the bands excised from an activity stained native electroblot
membrane confirmed the presence of OPH. OPH was not consistently
identified in band 1. P indicates the probability that the protein or peptide is a
random match to the spectral data.

However, there were significant increases in esterase activity staining with the chiral ANAA substrates. There was
approximately a seven-fold increase in esterase activity
staining with S-ANAA in the COS-7-OPH cells compared
to the non-transfected COS-7 cells. Moreover, there
was approximately 50% more esterase activity staining with

the S-isomer compared to the R-isomer. As indicated
in Figure 9C, SDS-PAGE Western blots of COS-7 and
COS-7-OPH lysates using anti-OPH antibody confirms
the marked overexpression of OPH in the COS-7-OPH
cells. Additionally, n-PAGE activity profiling with S-ANAA
and the OPH activity assay confirms the overexpression of
active OPH in the COS-7-OPH cells and also show the
OPH activity is present in two main bands (Figure 9D).
Lysates of COS-7 and COS-7-OPH were incubated with
AcApNA for 10 min and the p-NA released was compared
(Figure 9E). COS-7-OPH lysates showed approximately a
seven-fold higher p-NA release compared to COS-7 lysates.

Discussion and Conclusion
A number of investigators have suggested that chiral ester
prodrugs hold the promise of providing more selective anticancer chemotherapy [7-9,11,14]. A major requirement for
this strategy is the need to identify target esterases that have
differential expression or substrate selectivity in cancer cells
compared to their normal counterpart. Ideally, esterases
targeted for prodrug hydrolysis should be highly expressed
in the target tumor cells and/or have a chiral preference
different from normal cells. Yamazaki et al. previously
found that several cancers displayed hydrolytic preferences for isomers of chiral substrates opposite that of
their normal counterparts [13,14,32]. However, in the
work presented here we found that the esterases of
both tumorigenic and non-tumorigenic prostate cells both
showed a preference for the S-isomer of α-naphthyl
N-acetyl-alaninate (S-ANAA).
Additionally, we have improved upon the work by
Yamazaki et al. by identifying a specific esterase that
has differential activity towards chiral ANAA substrates.
We have used several proteomic techniques to identify
OPH in tumorigenic and non-tumorigenic prostate cells.
Using an n-PAGE method similar to Yamazaki et al.,
n-PAGE electroblotting, immunoblotting, inhibition
studies and mass spectrometry we have identified
OPH in prostate cells and have found that OPH has
selective activity towards chiral ANAA substrates.

Figure 6 Pre-clearance of OPH or inhibition by DFP ablates OPH activity bands. A) LNCaP and RWPE-1 lysates were separated by 6%
n-PAGE. The gel was pre-incubated in phosphate buffer or phosphate buffer containing 50 μM DFP for 30 min. Esterase activity bands were
visualized with S-ANAA and Fast Blue RR salt. B) LNCaP lysates containing 120 μg of protein were pre-cleared with protein A beads or anti-OPH
antibody bound to protein A beads. The collected lysates were separated by 6% n-PAGE and the esterase activity visualized with S-ANAA and Fast
Blue RR salt.
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Figure 7 OPH protein levels are differentially expressed in prostate cell lysates. A) RWPE-1, LNCaP, DU 145, and PC3 lysates containing
90 μg of protein were separated by 6% SDS-PAGE, transferred to a nitrocellulose membrane, and probed with anti-OPH antibody. Anti-OPH bands
were measured by densitometry and expressed in arbitrary units (A.U.). B) RWPE-1, LNCaP, DU 145, and PC3 lysates containing 90 μg of protein
were incubated with 4 mM AcApNA and the amount of p-nitroaniline released after 10 minutes were calculated. PLE (0.5 units) and semi-purified
rat liver OPH (250 ng) were used as negative and positive controls respectively. Letters that are not the same are significantly different at P < 0.05.

OPH is a serine protease and a member of the prolyl
oligopeptidase (POP) family. Three functions of OPH have
been described: (1) an exopeptidase activity that unblocks
N-acetyl peptides with a preference for N-acetyl alanyl peptides [16]; (2) an endopeptidase activity towards oxidized

and glycated proteins [28,33-36] and; (3) an ability to associate with aggresomes when proteasome function is inhibited [28]. Moreover, work by Shimizu et al. [28] suggests
that the proteasome and OPH work coordinately to clear
cells of oxidized (carbonylated) proteins. A comprehensive

Figure 8 LNCaP prostate cancer cells contain higher esterase activity than non-tumorigenic RWPE-1 cells. A) LNCaP and RWPE-1 cell
cultures were incubated with 800 μM α-naphthyl acetate, R-ANAA, or S-ANAA substrate and Fast Blue RR salt for 20 min. The dark color indicates in situ
esterase activity. B) Microscopy images were analyzed with ImageJ to measure the relative staining between cell lines. Percent area threshold was
defined as the percent area stained that exceeded background staining. Letters that are not the same are significantly different at P < 0.05.
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Figure 9 COS-7 cells that over-express OPH show higher levels of ANAA hydrolysis. A) COS-7 and COS-7-OPH cells were treated with
800 μM α-naphthyl acetate, R-ANAA, or S-ANAA substrate and Fast Blue RR salt for 20 minutes. Dark color indicates esterase activity. B) Microscopy
images were analyzed with ImageJ to measure the relative staining between cell lines. Percent area threshold was defined as the percent area
stained that exceeded background staining. C) Anti-OPH Western blot of COS-7 and COS-7-OPH lystates containing 90 μg of total protein. D) Cell
lysates containing 120 μg of protein were separated by 6% n-PAGE followed by staining with 800 μM S-ANAA. E) Lysates were incubated with
4 mM N-acetyl-L-alanyl-p-nitroanilide and the amounts of p-nitroanaline released after 10 minutes were measured. Letters that are not the same are
significantly different at P < 0.05.

physiological understanding of OPH remains elusive.
Nevertheless, the acetylation of the N-terminal α-amine
group of proteins is the most common post-translational
modification in eukaryotic proteins yet, little is known
about the biological role of N-alpha-terminal acetylation, and even less is known about the role of enzymes
(like OPH) that catalyze the hydrolysis of an N-terminally
acetylated peptide to release an N-acetylamino acid.
Our finding that OPH in non-tumorigenic and tumorigenic prostate cell lines have a greater hydrolytic preference
for the S-ANAA isomer of ANAA is consistent with
previous observations that OPH has a preference for small
peptides with Ac-L-alanine (Ac-S-alanine) compared to
Ac-D-alanine (Ac-R-alanine) [37]. OPH activity bands
were not observed with the α-naphthyl acetate substrate while distinct activity bands were visualized using
α-naphthyl N-acetyl-alaninate substrates. In addition,
OPH has high specificity for AcApNA and Ac-Ala-βnaphthylamide [16]. AcApNA and Ac-Ala-β-naphthylamide
are structurally similar to ANAA; the main differences
being the 4-nitrobenzene of AcApNA and the peptide
bond of Ac-Ala-β-naphthylamide. AcApNA, Ac-Ala-βnaphthylamide, and ANAA contain N-terminal acetylated
alanine. Taken together, this family of small N-acetylalaninate substrates appears to be good models for future OPH targeted prodrug designs.

We found OPH to be differentially expressed in the
LNCaP prostate cancer cell line compared to nontumorigenic RWPE-1 cell lines and that tumor cells
overexpressing OPH might be responsive to prodrug
derivatives of α-naphthyl N-acetyl-alaninate. We have
found that OPH expression in prostate cancer cells can
vary widely. DU-145 and PC3 lysates showed slightly
diminished levels of OPH compared to RWPE-1 while
LNCaP contained nearly twofold more OPH than RWPE1. OPH protein expression levels appear to vary in other
cancers as well. Serine protease activity profiling performed by Jessani et al. shows that OPH is highly active in
several melanoma and breast cancer cell lines [38]; however, Scaloni previously reported that OPH was deleted or
under-expressed in a number of small cell lung carcinomas [37]. We have screened other tumorigenic cell lines
for OPH activity and have found that several aggressive
colon cancer and melanoma cell lines exhibit significantly
higher OPH activity compared to their non-tumorigenic
counterparts. Further OPH expression profiling of normal
prostate cell lines, prostate cancer cell lines, and primary
prostate tissues is needed to determine which prostate
cancers might be suitable for OPH-targeted therapies.
OPH has recently been proposed as a potential target
for the development of anticancer drugs [39]. Histological
data in the Human Protein Atlas shows that OPH can be
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strongly expressed in some cases of colorectal, breast,
prostate, ovarian, endometrial and liver cancers [40].
OPH has a well-documented substrate specificity towards N-acetylated-L-alaninate esters [41]. Our results
suggest that α-naphthyl N-acetyl-alaninate substrates
could be used to rapidly determine levels of active OPH
in non-tumorigenic and tumorigenic cells and tissues.
Naphthyl substrates are routinely used to differentiate
chronic myelogenous leukemia (CML) from leukemoid
reaction and to distinguish other myeloproliferative disorders [42,43]. Yamazaki et al. demonstrated that a substrate similar to S-ANAA, N-methoxycarbonylalaninate,
could be used to visualize esterase activity in cryostat
tissue sections [32]. Our cell culture activity staining of
RWPE-1, LNCaP, and COS-7-OPH cells with S-ANAA
suggest that S-ANAA may be useful to screen cells and
tissues for relative OPH activity. Screening normal and
tumorigenic cells or tissues with S-ANAA may aid in
identifying candidates for OPH directed therapies.
In conclusion, we have found that cell lysates from
non-tumorigenic RWPE-1 cells and several tumorigenic
prostate cell lines display differential esterase activity
profiles when visualized with α-naphthyl acetate or chiral
α-naphthyl N-acetyl-alaninate substrates. Our n-PAGE
results show that tumorigenic LNCaP, DU 145, and PC3
cell lysates contain higher general esterase activity when
visualized with α-naphthyl acetate compared to nontumorigenic RWPE-1 cell lysates. In addition, we found
that the OPH activity of prostate cell lysates could be visualized by staining with chiral α-naphthyl N-acetyl-alaninate
substrates, and that OPH has a hydrolytic preference for
the S-isomer of ANAA. LNCaP lysates in particular showed
the highest esterase activity with all of the ester substrates
tested and contained the highest OPH activity measured
with AcApNA. The results of this study indicate that ester
prodrugs designed after S-ANAA or AcApNA may be
a promising therapeutic approach to prostate cancers
that overexpress OPH.
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